Related Experiment Videos

Reduced cardiac functional reserve and quality of life in adults with GH deficiency

Robert Moisey1, Diane Barker, Nigel Lewis

  • 1Department of Endocrinology, Leeds General Infirmary, Great George Street, Leeds, United Kingdom.

Insights

Patients with severe Growth Hormone Deficiency (GHD) exhibit impaired cardiac functional reserve, including reduced peak cardiac power and chronotropic incompetence. This impairment, however, does not correlate with their quality of life scores.

Area of Science:

  • Cardiology
  • Endocrinology
  • Exercise Physiology

Background:

  • Severe Growth Hormone Deficiency (GHD) is linked to reduced quality of life and cardiac alterations.
  • The impact of GHD on cardiac reserve during peak exercise remains largely unquantified.
  • This study investigates if impaired cardiac reserve in GHD patients contributes to their diminished quality of life.

Purpose of the Study:

  • To test the hypothesis that severe GHD patients have reduced cardiac reserve function compared to healthy controls.
  • To assess if this reduced cardiac reserve explains, in part, their reduced quality of life.

Main Methods:

  • Eighteen severe GHD patients and 18 matched healthy controls underwent maximal cardiopulmonary exercise testing.
  • Noninvasive hemodynamic measurements assessed peak cardiac power and cardiorespiratory fitness.
  • The Assessment of GHD in Adults (AGHDA) score was used to evaluate GHD severity.

Main Results:

  • GHD patients showed a 15% reduction in peak cardiac power during maximal exercise compared to controls (4.4 ± 1.0 W vs. 5.2 ± 1.0 W, P = 0.02).
  • Patients exhibited significantly lower cardiac chronotropic reserve (peak heart rate 154 ± 21/min vs. 174 ± 11/min, P = 0.001) and impaired pressure-generating capacity (systolic blood pressure 160 ± 25 mmHg vs. 200 ± 15 mmHg, P < 0.0001).
  • No correlation was found between cardiac function measures and the AGHDA score.

Conclusions:

  • Severe GHD is associated with significantly impaired cardiac functional reserve, characterized by chronotropic incompetence and reduced pressure-generating capacity.
  • Despite impaired cardiac function, this study found no correlation with quality of life as assessed by the AGHDA score.
  • Noninvasive assessment of functional cardiac pumping capacity reveals novel insights into GHD pathophysiology.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...